A peptoid interleukin‐15 receptor antagonist suppresses inflammation and arthritis in mice
Abstract Objective To discover a novel peptoid antagonist that targets the interleukin‐15 (IL‐15) receptor and to evaluate its therapeutic efficacy in the treatment of inflammation and arthritis. Methods A new compound (IFRA3, interleukin‐15 receptor antagonist 3) was discovered using a unique on‐be...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Wiley
2022-01-01
|
| Cyfres: | Clinical & Translational Immunology |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1002/cti2.1432 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
